Application no. and date | 13730652.8 (espacenet) (Federated) (European Patent Register), 20130509 | Patent/reg. no. and date | DK/EP 2861579, 20180221 | Publication date | 20150422 | Priority no. and date | US 201261647174 P, 20120515, US 201361790967 P, 20130315 | EP pub. no. and date |
EP 2861579 20150422 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | 156894/BT/GP | Inventor | DODD, Stephanie Kay, Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue,
Cambridge, Massachusetts 02139, US, FURET, Pascal, Novartis Pharma AG, Werk Klybeck Postfach,
4002 Basel, CH, GROTZFELD, Robert Martin, Novartis Pharma AG, Forum 1 Novartis Campus,
4056 Basel, CH, JONES, Darryl Brynley, Novartis Pharma AG, Forum 1 Novartis Campus,
4056 Basel, CH, MANLEY, Paul, Novartis Pharma AG, Werk Klybeck Postfach,
4002 Basel, CH, MARZINZIK, Andreas, Novartis Pharma AG, Werk Klybeck Postfach,
4002 Basel, CH, PELLE, Xavier Francois Andre, Novartis Pharma AG, Forum 1 Novartis Campus,
4056 Basel, CH, SALEM, Bahaa, Novartis Pharma AG, Werk Klybeck Postfach,
4002 Basel, CH, SCHOEPFER, Joseph, Novartis Pharma AG, Werk Klybeck Postfach,
4002 Basel, CH, JAHNKE, Wolfgang, Novartis Pharma AG, Postfach,
4002 Basel, CH | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 213/82 (2006.01) , C07D 401/04 (2006.01) , C07D 401/14 (2006.01) , C07D 403/10 (2006.01) | Title | Benzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1 | Int. application no. | IB2013053768 | Int. publication no. | WO2013171639 | Related patent (certificate) | CA 2022 00046 | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|